Lamotrigine-induced fulminant hepatic failure: an unusual presentation

M. C. Gupta, J. Khanna, R. Mathur, N. Mittal

Abstract


Lamotrigine (LTG) is indicated for the management of seizures either alone or in combination with other anticonvulsant agents. Adverse effects with it are usually mild. Less than 1% of subjects show deranged liver function tests during long therapy. Fulminant hepatic failure with LTG is an unusual presentation. We report a fatal case of hepatic failure with LTG monotherapy in a 22-year-old male patient suffering from a seizure disorder. Cases of LTG induced hepatotoxicity should be carefully monitored, particularly serious case of fulminant hepatic failure which should be adequately assessed and reported to determine their exact incidence.


Keywords


Lamotrigine, Hepatic failure

Full Text:

PDF

References


World Health Organisation. Factsheet: epilepsy, October 2012. Available at http://www.who.int/mediacentre/factsheets/fs999/en/. Accessed on 12 October 2014

GlaxoSmithKline. Lamictal Prescribing Information, May 2007. Available at https://www.gsksource.com/gskprm/htdocs/documents/LAMICTAL-PI-MG.PDF. Accessed on 12 October 2014.

Guberman AH, Besag FM, Brodie MJ, Dooley JM, Duchowny MS, Pellock JM, et al. Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia. 1999;40(7):985-91.

Cash WJ, McConville P, McDermott E, McCormick PA, Callender ME, McDougall NI. Current concepts in the assessment and treatment of hepatic encephalopathy. QJM. 2010;103(1):9-16.

Arnon R, DeVivo D, Defelice AR, Kazlow PG. Acute hepatic failure in a child treated with lamotrigine. Pediatr Neurol. 1998;18:251-2.

Fayad M, Choueiri R, Mikati M. Potential hepatotoxicity of lamotrigine. Pediatr Neurol. 2000;22(1):49-52.

Makin AJ, Fitt S, Williams R, Duncan JS. Fulminant hepatic failure induced by lamotrigine. BMJ. 1995;311(7000):292.

Mecarelli O, Pulitano P, Mingoia M, Ferretti G, Rossi M, Berloco PB, et al. Acute hepatitis associated with lamotrigine and managed with the molecular adsorbents recirculating system (Mars). Epilepsia. 2005;46(10):1687-9.

Overstreet K, Costanza C, Behling C, Hassanin T, Masliah E. Fatal progressive hepatic necrosis associated with lamotrigine treatment: a case report and literature review. Dig Dis Sci. 2002;47(9):1921-5.

Schaub JE, Williamson PJ, Barnes EW, Trewby PN. Multisystem adverse reaction to lamotrigine. Lancet. 1994;344(8920):481.

Moeller KE, Wei L, Jewell AD, Carver LA. Acute hepatotoxicity associated with lamotrigine. Am J Psychiatry. 2008;165(4):539-40.

Amante MF, Filippini AV, Cejas N, Lendoire J, Imventarza O, Parisi C. Dress syndrome and fulminant hepatic failure induced by lamotrigine. Ann Hepatol. 2009;8(1):75-7.

Could Lamictal cause sudden death? Ehealth Me.com. Available at http://www.ehealthme.com/ds/lamictal/sudden+death+unexplained. Accessed on 12 October 2014.

Leeder JS, Riley RJ, Cook VA, Spielberg SP. Human anti-cytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions. J Pharmacol Exp Ther. 1992;263(1):360-7.

Gotthardt D, Riediger C, Weiss KH, Encke J, Schemmer P, Schmidt J, et al. Fulminant hepatic failure: etiology and indications for liver transplantation. Nephrol Dial Transplant. 2007;22 Suppl 8:viii5-8.